Publication | Closed Access

Genetically re-engineered K562 cells significantly expand and functionally activate cord blood natural killer cells: Potential for adoptive cellular immunotherapy

Cell TherapyMedicineImmunologyRe-engineered K562 CellsCell Replacement TherapyCell BiologyAdoptive Cellular ImmunotherapyImmunotherapyCell EngineeringCell TransplantationNatural Killer Cells